Capturing the $25 Billion Opportunity in the Global Genetic Testing Industry
How Genetic Testing Is Scaling Across Modern HealthcareDownload the Whitepaper Now
Population screening initiatives, expanding prenatal and newborn programs, and growing adoption in predictive and presymptomatic care are steadily broadening the role of germline genetic testing across the care continuum. At the same time, digital platforms, bioinformatics, and AI-based interpretation are changing how genetic insights are generated, interpreted, and applied at scale.
This whitepaper takes a closer look at how these forces are reshaping the global genetic testing landscape and where growth is likely to take shape up to the end of the decade.
What This Whitepaper Explores
Expansion of prenatal and newborn screening, predictive testing, and in vitro fertilization (IVF)-related genetic services across clinical workflows and population-level programs.
The role of sequencing platforms, assay kits, software, and bioinformatics in supporting genetic testing across diagnostics, reproductive health, and personalized medicine.
The convergence of laboratory testing with digital health tools, AI-driven interpretation, and population genomics initiatives to enable more consistent clinical decision-making.
Discover which strategies are driving scale in genetic testing and where your organization can build advantage as adoption accelerates.